Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medic

According to the new market research report " Anatomic pathology by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease ) - Forecasts to 2021", published by MarketsandMarkets™, The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021.

Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Target Audience for this Report:

• Anatomic pathology instrument manufacturers- Anatomic pathology consumable manufacturers- Anatomic pathology product distributors- Various research and consulting companies- Various research associations related to anatomic pathology

Anatomic Pathology Market segmented into :

• On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.
• On the basis of product and service, the market is segmented into instruments, consumables, and services. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

Get Sample Copy of This Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

Geographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.

The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

The anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1%.

On the basis of product and service, the market is segmented into instruments, consumables, and services. In 2016, the services segment accounted for the largest share of the anatomical pathology market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

On the basis of application, the market is segmented into disease diagnosis, drug discovery & development, and others applications. In 2016, the disease diagnosis segment accounted for the largest share of the Anatomical pathology market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.

Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137323145

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.